Cargando…
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
AIMS/HYPOTHESIS: Concerns have been raised regarding a potential association of use of the incretin-based drugs dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists with risk of cholangiocarcinoma. We examined this association in nationwide data from three c...
Autores principales: | Ueda, Peter, Wintzell, Viktor, Melbye, Mads, Eliasson, Björn, Svensson, Ann-Marie, Franzén, Stefan, Gudbjörnsdottir, Soffia, Hveem, Kristian, Jonasson, Christian, Svanström, Henrik, Pasternak, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423638/ https://www.ncbi.nlm.nih.gov/pubmed/34254177 http://dx.doi.org/10.1007/s00125-021-05508-1 |
Ejemplares similares
-
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
por: Pasternak, Björn, et al.
Publicado: (2020) -
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
por: Pasternak, Björn, et al.
Publicado: (2019) -
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
por: Ueda, Peter, et al.
Publicado: (2018) -
Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
por: Wintzell, Viktor, et al.
Publicado: (2020) -
Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
por: Liakopoulos, Vasileios, et al.
Publicado: (2017)